Type 2B von Willebrand disease in seven individuals from three different families : Phenotypic and genotypic characterizationSZANTO, Timea; SCHLAMMADINGER, Agota; SALLES, Isabelle et al.Thrombosis and haemostasis. 2007, Vol 98, Num 1, pp 251-254, issn 0340-6245, 4 p.Article

The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutationJACKSON, Shannon C; SINCLAIR, Gary D; CLOUTIER, Stephanie et al.Blood. 2009, Vol 113, Num 14, pp 3348-3351, issn 0006-4971, 4 p.Article

Type 2B-like acquired von Willebrand syndromeSHIGEKIYO, Toshio; SEKIMOTO, Etsuko; SHIRAKAMI, Atsuhisa et al.International journal of hematology. 2011, Vol 94, Num 4, pp 410-412, issn 0925-5710, 3 p.Article

Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2BNURDEN, Paquita; GOBBI, Giuliana; VITALE, Marco et al.Blood. 2010, Vol 115, Num 13, pp 2649-2656, issn 0006-4971, 8 p.Article

The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand diseaseJILMA-STOHLAWETZ, Petra; KNÖBL, Paul; GILBERT, James C et al.Thrombosis and haemostasis. 2012, Vol 108, Num 2, pp 284-290, issn 0340-6245, 7 p.Article

A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand diseaseJILMA, Bernd; PAULINSKA, Petra; JILMA-STOHLAWETZ, Petra et al.Thrombosis and haemostasis. 2010, Vol 104, Num 3, pp 563-570, issn 0340-6245, 8 p.Article

Platelet-Type von Willebrand Disease and Type 2B von Willebrand Disease : A Story of Nonidentical Twins when Two Different Genetic Abnormalities Evolve into Similar PhenotypesOTHMAN, Maha.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 8, pp 780-786, issn 0094-6176, 7 p.Article

Maladie de willebrand de type 2B et pseudomaladie de willebrand de type 2B ; à propos de trois observations = Type 2B and pseudo type 2B von willebrand disease; a report of three casesGUERMAZI, S; CONARD, J; SAMAMA, M. M et al.Pathologie et biologie. 2006, Vol 54, Num 3, pp 159-165, issn 0369-8114, 7 p.Article

Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopeniaCASONATO, Alessandra; GALLINARO, Lisa; GRAZIA CATTINI, Maria et al.Haematologica (Roma). 2010, Vol 95, Num 8, pp 1366-1372, issn 0390-6078, 7 p.Article

Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in childrenFRONTROTH, Juan Pablo; HEPNER, Mirta; SCIUCCATI, Gabriela et al.Thrombosis and haemostasis. 2010, Vol 104, Num 6, pp 1158-1165, issn 0340-6245, 8 p.Article

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B : a cohort study of 67 patients. CommentaryMONTGOMERY, Robert R; FEDERICI, Augusto B; MANNUCCI, Pier M et al.Blood. 2009, Vol 113, Num 3, issn 0006-4971, 501, 526-534 [10 p.]Article

Type 2B von Willebrand's disease due to Val1316Met mutation. Heterogeneity in the same sibshipRENDAL, E; PENAS, N; LARRABEITI, B et al.Annals of hematology (Print). 2001, Vol 80, Num 6, pp 354-360, issn 0939-5555Article

Frequency of Platelet type versus Type 2B von Willebrand Disease: An international registry-based studyHAMILTON, Alexander; OZELO, Margareth; LILLICRAP, David et al.Thrombosis and haemostasis. 2011, Vol 105, Num 3, pp 501-508, issn 0340-6245, 8 p.Article

Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutionsGOLDER, Mia; PRUSS, Cynthia M; HEGADORN, Carol et al.Blood. 2010, Vol 115, Num 23, pp 4862-4869, issn 0006-4971, 8 p.Article

Efficacy of Haemate-P as prophylaxis of recurrent bleeding in a patient with type 2B von Willebrand's diseaseFRANCHINI, Massimo; GIUFFRIDA, Annachiara; GANDINI, Giorgio et al.Blood coagulation & fibrinolysis. 2005, Vol 16, Num 8, pp 571-572, issn 0957-5235, 2 p.Article

Mutation and ADAMTS 13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2BRAYES, Julie; HOLLESTELLE, Martine J; LEGENDRE, Paulette et al.Blood. 2010, Vol 115, Num 23, pp 4870-4877, issn 0006-4971, 8 p.Article

Genetics of type 2B von Willebrand Disease : True 2B, tricky 2B, or Not 2B. What Are the Modifiers of the Phenotype?OTHMAN, Maha; FAVALORO, Emmanuel J.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 6, pp 520-531, issn 0094-6176, 12 p.Article

Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndromeKARGER, Ralf; WEIPPERT-KRETSCHMER, Monika; BUDDE, Ulrich et al.Blood coagulation & fibrinolysis. 2011, Vol 22, Num 2, pp 144-147, issn 0957-5235, 4 p.Article

Phenotypic Identification of Platelet-Type von Willebrand Disease and Its Discrimination from Type 2B von Willebrand Disease : A Question of 2B or Not 2B? A Story of Nonidentical Twins? Or Two Sides of a Multidenominational or Multifaceted Primary-Hemostasis Coin?FAVALORO, Emmanuel J.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 1, pp 113-127, issn 0094-6176, 15 p.Article

Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia. CommentaryFEDERICI, Augusto B; NURDEN, Paquita; NURDEN, Alan T et al.Blood. 2006, Vol 108, Num 8, issn 0006-4971, 2498-2499,2587-2595 [11 p.]Article

Distinguishing between type 2B and pseudo-von willebrand disease and its clinical importanceENAYAT, Mohammad S; GUILLIATT, Andrea M; LESTER, William et al.British journal of haematology. 2006, Vol 133, Num 6, pp 664-666, issn 0007-1048, 3 p.Article

A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease : An elusive phenotype and a difficult diagnosisCASONATO, Alessandra; SARTORELLO, Francesca; PONTARA, Elena et al.Thrombosis and haemostasis. 2007, Vol 98, Num 6, pp 1182-1187, issn 0340-6245, 6 p.Article

Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein ibα in an enzyme-linked immunosorbent assay-based method : performances in patients with type 2B von Willebrand diseaseCARON, Claudine; HILBERT, Lysiane; VANHOORELBEKE, Karen et al.British journal of haematology. 2006, Vol 133, Num 6, pp 655-663, issn 0007-1048, 9 p.Article

Activation of pp125FAK by type 2B recombinant von Willebrand factor binding to platelet GPIb at a high shear rate occurs independently of αIIbβ3 engagementMEKRACHE, Médina; BACHELOT-LOZA, Christilla; AJZENBERG, Nadine et al.Blood. 2003, Vol 101, Num 11, pp 4363-4371, issn 0006-4971, 9 p.Article

Alterations in the intrinsic properties of the GPIbα-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233ValDOGGETT, Teresa A; GIRDHAR, Gaurav; LAWSHE, Avril et al.Blood. 2003, Vol 102, Num 1, pp 152-160, issn 0006-4971, 9 p.Article